News | Analytics Software | October 30, 2015

Societies Release Statement on the Future of Clinical Registries

Registries can support development, implementation and evaluation of performance measures

October 30, 2015 — The American College of Cardiology, the American Heart Association and The Society of Thoracic Surgeons released a new statement in early October on the future of clinical registries titled ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise.

Clinical registries are observational databases focused on clinical conditions, procedures, therapies or populations. The goal of registries is to capture data that reflect real-world clinical practice in patient populations.

“Registries are fundamental to healthcare quality and improvement,” said Deepak L. Bhatt, M.D., M.P.H., FACC, FAHA, executive director of intervention cardiovascular programs at Brigham and Women’s Hospital Heart and Vascular Center, professor of medicine at Harvard Medical School, and chair of the writing committee. “Registries can support the development, implementation and evaluation of performance measures as tools for improving patient care and communicating meaningful information to patients regarding quality.”

The statement examines the current state of clinical registries while acknowledging their future growth potential.  The authors write that while there has been an “explosion” in the number of clinical registries over the past decade, there are still broad clinical areas and specific procedures that would benefit from the creation of a dedicated registry.

“The future will likely involve some degree of integration of electronic health records and administrative data sources with registry data,” Bhatt said.

The document was published online in the Journal of the American College of Cardiology, Circulation: Cardiovascular Quality and Outcomes and The Annals of Thoracic Surgery.

For more information: www.acc.org, www.heart.org, www.sts.org


Related Content

News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
Subscribe Now